Perioperative allogeneic red blood-cell transfusion associated with surgical site infection after total hip and knee arthroplasty

Journal of Bone and Joint Surgery - American Volume

Volumn 100, Issue 4, 2018, Pages 288-294

  Everhart, Joshua S ^a,b   Sojka, John H ^a,b   Mayerson, Joel L ^a,b   Glassman, Andrew H ^a,b   Scharschmidt, Thomas J ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FEMALE; HIP ARTHROPLASTY; HOSPITAL PLANNING; HUMAN; INFECTION RATE; INFECTION RISK; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL INFECTION; SURGICAL RISK; TISSUE INJURY; AGED; COHORT ANALYSIS; HIP REPLACEMENT; KNEE REPLACEMENT; MIDDLE AGED; STATISTICAL MODEL;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 85047805005     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.17.00237     Document Type: Article

References (56)

1. Paxton EW, Inacio MC, Kiley ML. The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities. Perm J. 2012 Spring;16(2):36-44.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.
3. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009 Sep;24(6)(Suppl):84-8. Epub 2009 Jul 15.
4. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007 Apr;89(4):871-82.
5. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992 Oct;13 (10):606-8.
6. Poultsides LA, Ma Y, Della Valle AG, Chiu YL, Sculco TP, Memtsoudis SG. In-hospital surgical site infections after primary hip and knee arthroplasty—incidence and risk factors. J Arthroplasty. 2013 Mar;28(3):385-9. Epub 2012 Nov 8.
7. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014 Apr;27 (2):302-45.
8. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014 Feb 19;96(4):272-8.
9. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003 May;85(4):484-9.
10. Carroll K, Dowsey M, Choong P, Peel T. Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect. 2014 Feb;20 (2):130-5. Epub 2013 Apr 10.
11. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res. 2008 Jan;466(1):153-8. Epub 2008 Jan 3.
12. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion. 2005 Jan;45(1):103-10.
13. Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am. 2014 Feb 19;96(4):279-84.
14. Vamvakas EC. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results? Vox Sang. 2007 Oct;93(3):196-207.
15. Vamvakas EC. Purported deleterious effects of “old” versus “fresh” red blood cells: an updated meta-analysis. Transfusion. 2011 May;51(5):1122-3.
16. Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3112-9.
17. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012 Oct;470(10):2695-701.
18. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am. 2014 Dec 3;96(23):1945-51.
19. Myers E, O’Grady P, Dolan AM. The influence of preclinical anaemia on outcome following total hip replacement. Arch Orthop Trauma Surg. 2004 Dec;124(10):699-701. Epub 2004 Oct 29.
20. Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004 Jul;18(6):369-74.
21. Rogers BA, Cowie A, Alcock C, Rosson JW. Identification and treatment of anaemia in patients awaiting hip replacement. Ann R Coll Surg Engl. 2008 Sep;90 (6):504-7.
22. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011 Nov;469(11):2992-4.
23. Everhart JS, Andridge RR, Scharschmidt TJ, Mayerson JL, Glassman AH, Lemeshow S. Development and validation of a preoperative surgical site infection risk score for primary or revision knee and hip arthroplasty. J Bone Joint Surg Am. 2016 Sep 21;98(18):1522-32.
24. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011. http://www.who.int/vmnis/indicators/haemoglobin.pdf. Accessed 2017 Sep 6.
25. Long K, Meier C, Bernard A, Williams D, Davenport D, Woodward J. T-cell suppression by red blood cells is dependent on intact cells and is a consequence of blood bank processing. Transfusion. 2014 May;54(5):1340-7. Epub 2013 Nov 4.
26. Leal-Noval SR, Muñoz-Gómez M, Arellano V, Adsuar A, Jiménez-Sánchez M, Corcia Y, Leal M. Influence of red blood cell transfusion on CD41 T-helper cells immune response in patients undergoing cardiac surgery. J Surg Res. 2010 Nov;164 (1):43-9. Epub 2009 Apr 18.
27. Theodoraki K, Markatou M, Rizos D, Fassoulaki A. The impact of two different transfusion strategies on patient immune response during major abdominal surgery: a preliminary report. J Immunol Res. 2014;2014:945829. Epub 2014 Apr 3.
28. Neal MD, Raval JS, Triulzi DJ, Simmons RL. Innate immune activation after transfusion of stored red blood cells. Transfus Med Rev. 2013 Apr;27(2):113-8. Epub 2013 Feb 21.
29. Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg. 2010 Mar;18(3):132-8.
30. Harley BJ, Beaupré LA, Jones CA, Cinats JG, Guenther CR. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg. 2002 Jun;45(3):185-90.
31. Banerjee S, Issa K, Pivec R, McElroy MJ, Khanuja HS, Harwin SF, Mont MA. Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg. 2013 Dec;26(6):379-85. Epub 2013 Aug 16.
32. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, Brand A. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013 Apr;11(2):289-95. Epub 2013 Feb 6.
33. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012 Apr 18;4:CD002042.
34. Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology. 2008 Jan;108(1):71-7.
35. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet. 1996 Feb 3;347(8997):289-92.
36. Banerjee S, Issa K, Kapadia BH, Khanuja HS, Harwin SF, McInerney VK, Mont MA. Intraoperative nonpharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg. 2013 Dec;26(6):387-93. Epub 2013 Aug 19.
37. Niemi TT, Pitkänen M, Syrjälä M, Rosenberg PH. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand. 2000 Apr;44(4):457-64.
38. Kleinert K, Theusinger OM, Nuernberg J, Werner CM. Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery. HSS J. 2010 Sep;6(2):190-8. Epub 2010 Jan 28.
39. Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN. A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion. 1992 Oct;32(8):742-6.
40. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006;4:CD001888.
41. Perazzo P, Viganò M, De Girolamo L, Verde F, Vinci A, Banfi G, Romagnoli S. Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. Blood Transfus. 2013 Jul;11(3):370-6. Epub 2013 May 7.
42. Benjamin JB, Colgan KM. Are routine blood salvage/preservation measures justified in all patients undergoing primary TKA and THA? J Arthroplasty. 2015 Jun;30 (6):955-8. Epub 2015 Jan 23.
43. Muñoz M, Gómez-Ramírez S, Cuenca J, García-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, Ariza D, Naveira E. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014 Feb;54 (2):289-99. Epub 2013 Apr 15.
44. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014 Jul;12(3):296-300.
45. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013 Aug 15;347:f4822.
46. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 Mar 10;352(10):1011-23.
47. Andrews CM, Lane DW, Bradley JG. Iron pre-load for major joint replacement. Transfus Med. 1997 Dec;7(4):281-6.
48. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004 Dec;19(12):2021-32. Epub 2004 Aug 30.
49. Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth. 2005 Apr;52(4):362-8.
50. Faris PM, Ritter MA, Abels RI; The American Erythropoietin Study Group. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg Am. 1996 Jan;78(1):62-72.
51. Kotzé A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012 Jun;108(6):943-52.
52. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013 May 25;381(9880):1855-65.
53. Calderwood MS, Ma A, Khan YM, Olsen MA, Bratzler DW, Yokoe DS, Hooper DC, Stevenson K, Fraser VJ, Platt R, Huang SS; CDC Prevention Epicenters Program. Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol. 2012 Jan;33(1):40-9. Epub 2011 Nov 22.
54. Rodriguez-Merchan EC. Preventing surgical site infection in haemophilia patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis. 2012 Sep;23 (6):477-81.
55. Wong JM, Mann HA, Goddard NJ. Perioperative clotting factor replacement and infection in total knee arthroplasty. Haemophilia. 2012 Jul;18(4):607-12. Epub 2011 Dec 20.
56. McDougall CJ, Gray HS, Simpson PM, Whitehouse SL, Crawford RW, Donnelly WJ. Complications related to therapeutic anticoagulation in total hip arthroplasty. J Arthroplasty. 2013 Jan;28(1):187-92.